Santen Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Santen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014319
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Santen Inc (Santen), a subsidiary of Santen Pharmaceutical Co Ltd is a developer, manufacturer and distributor of ophthalmic pharmaceutical products. The company offers products in therapeutic areas such as retinal disorders, glaucoma and corneal diseases. It conducts diagnosis on uveitis conditions such as sight-threatening intraocular inflammation of autoimmune, infectious or unknown etiology. Santen partners with other pharma companies to develop its products in various therapeutic areas. The company markets its products through its distributors across the US. Santen is headquartered in Emeryville, California, the US.

Santen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Santen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Santen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Santen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Santen Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Santen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Santen Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Clearside Biomedical Raises US$8 Million In Venture Financing 10
Partnerships 12
Aequus Pharma Enters into Agreement with Santen 12
Santen Enters into Research Agreement with twoXAR 13
Santen Expands Research Agreement with Clearside Biomedical 14
Santen Enters Into Research Agreement With Clearside Biomedical 15
Santen Inc – Key Competitors 16
Santen Inc – Key Employees 17
Santen Inc – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Santen Inc, Pharmaceuticals & Healthcare, Key Facts 2
Santen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Santen Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Santen Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Santen Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Santen Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Clearside Biomedical Raises US$8 Million In Venture Financing 10
Aequus Pharma Enters into Agreement with Santen 12
Santen Enters into Research Agreement with twoXAR 13
Santen Expands Research Agreement with Clearside Biomedical 14
Santen Enters Into Research Agreement With Clearside Biomedical 15
Santen Inc, Key Competitors 16
Santen Inc, Key Employees 17

★海外企業調査レポート[Santen Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Energen Corporation:企業の戦略・SWOT・財務情報
    Energen Corporation - Strategy, SWOT and Corporate Finance Report Summary Energen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rallye SA:戦略・SWOT・企業財務分析
    Rallye SA - Strategy, SWOT and Corporate Finance Report Summary Rallye SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • RadiSys Corp (RSYS):企業の財務・戦略的SWOT分析
    Summary RadiSys Corp (RadiSys) is a provider of communication services. The company offers products include mobility engine, mediaengine, dcengine and embedded Products. It offers contact support, serviceengine, conceptualization, software customization, network design and integration; testing and a …
  • Euticals SpA-製薬・医療分野:企業M&A・提携分析
    Summary Euticals SpA (Euticals) is a chemical company that develops and supplies active pharmaceutical ingredients, fine chemicals and contract manufacturing. The company possess technologies and capabilities in the domains of fermentation and enzymatic chemistry; boronic acids, biaryls, grignards a …
  • SEAKR Engineering, Inc.:企業の戦略・SWOT・財務情報
    SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary SEAKR Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • TSI Holdings Co., Ltd.:企業の戦略・SWOT・財務情報
    TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary TSI Holdings Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • National Institute of Neurological Disorders and Stroke-製薬・医療分野:企業M&A・提携分析
    Summary National Institute of Neurological Disorders and Stroke (NINDS), a subsidiary of National Institutes of Health is a healthcare research institute that conducts and supports research on brain and nervous system disorders. The institute’s clinical research areas include Alzheimer’s disease, br …
  • Sunrise Coal LLC:企業の戦略・SWOT・財務分析
    Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report Summary Sunrise Coal LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務情報
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nolato AB (NOLA B):企業の財務・戦略的SWOT分析
    Nolato AB (NOLA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • M3 Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary M3 Biotechnology Inc (M3 Biotech) is a therapeutics company that concentrates on novel platform of pharmaceuticals that modifies growth-factor systems. The company provides therapies primarily for the treatment of neurodegenerative diseases. It develops small molecule modulators with a conce …
  • Besins Healthcare SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Besins Healthcare SA (Besins) is a pharmaceutical company that develops drugs for the well-being of men and women. The company offers AndroGel, a topical testosterone gel for hypogonadism. It also provides Oestrogel, a transdermal estradiol gel. Besins’ women's health products are used for t …
  • Vale Canada Ltd:企業の戦略・SWOT・財務分析
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Syngene International Ltd (SYNGENE):企業の財務・戦略的SWOT分析
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It also provides discovery chemistry, discovery biology, large molecule development, safety assess …
  • Mount Tam Biotechnologies Inc (MNTM):製薬・医療:M&Aディール及び事業提携情報
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that offers development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamycin analog …
  • Oswaldo Cruz Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Oswaldo Cruz Foundation (Oswaldo Cruz) is a provider of research and development in biological sciences. It offers research programs and technological development projects in vaccines production, medications, drugs, reagents and diagnostic kits. The foundation provides research in experiment …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務分析
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Bandera Electric Cooperative Inc:企業の戦略的SWOT分析
    Bandera Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Celanese Corporation:企業の戦略・SWOT・財務情報
    Celanese Corporation - Strategy, SWOT and Corporate Finance Report Summary Celanese Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Southern Co:発電所・企業SWOT分析
    Southern Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆